The expressions of FGF2 and its receptor, FGFR1, are both increased in a subset of stromal cell lines and primary AML stroma, and the increased FGF2/FGFR1 signaling is associated with enhanced exosome secretion. This evidence concerns the gene FGF2 and acute myeloid leukemia.